Cargando…

Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study

BACKGROUND: Opportunely screening for diabetes is crucial to reduce its related morbidity, mortality, and socioeconomic burden. Machine learning (ML) has excellent capability to maximize predictive accuracy. We aim to develop ML-augmented models for diabetes screening in community and primary care s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, XiaoHuan, Zhang, Weiyue, Zhang, Qiao, Chen, Long, Zeng, TianShu, Zhang, JiaoYue, Min, Jie, Tian, ShengHua, Zhang, Hao, Huang, Hantao, Wang, Ping, Hu, Xiang, Chen, LuLu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742532/
https://www.ncbi.nlm.nih.gov/pubmed/36518245
http://dx.doi.org/10.3389/fendo.2022.1043919
_version_ 1784848540656205824
author Liu, XiaoHuan
Zhang, Weiyue
Zhang, Qiao
Chen, Long
Zeng, TianShu
Zhang, JiaoYue
Min, Jie
Tian, ShengHua
Zhang, Hao
Huang, Hantao
Wang, Ping
Hu, Xiang
Chen, LuLu
author_facet Liu, XiaoHuan
Zhang, Weiyue
Zhang, Qiao
Chen, Long
Zeng, TianShu
Zhang, JiaoYue
Min, Jie
Tian, ShengHua
Zhang, Hao
Huang, Hantao
Wang, Ping
Hu, Xiang
Chen, LuLu
author_sort Liu, XiaoHuan
collection PubMed
description BACKGROUND: Opportunely screening for diabetes is crucial to reduce its related morbidity, mortality, and socioeconomic burden. Machine learning (ML) has excellent capability to maximize predictive accuracy. We aim to develop ML-augmented models for diabetes screening in community and primary care settings. METHODS: 8425 participants were involved from a population-based study in Hubei, China since 2011. The dataset was split into a development set and a testing set. Seven different ML algorithms were compared to generate predictive models. Non-laboratory features were employed in the ML model for community settings, and laboratory test features were further introduced in the ML+lab models for primary care. The area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (auPR), and the average detection costs per participant of these models were compared with their counterparts based on the New China Diabetes Risk Score (NCDRS) currently recommended for diabetes screening. RESULTS: The AUC and auPR of the ML model were 0·697and 0·303 in the testing set, seemingly outperforming those of NCDRS by 10·99% and 64·67%, respectively. The average detection cost of the ML model was 12·81% lower than that of NCDRS with the same sensitivity (0·72). Moreover, the average detection cost of the ML+FPG model is the lowest among the ML+lab models and less than that of the ML model and NCDRS+FPG model. CONCLUSION: The ML model and the ML+FPG model achieved higher predictive accuracy and lower detection costs than their counterpart based on NCDRS. Thus, the ML-augmented algorithm is potential to be employed for diabetes screening in community and primary care settings.
format Online
Article
Text
id pubmed-9742532
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97425322022-12-13 Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study Liu, XiaoHuan Zhang, Weiyue Zhang, Qiao Chen, Long Zeng, TianShu Zhang, JiaoYue Min, Jie Tian, ShengHua Zhang, Hao Huang, Hantao Wang, Ping Hu, Xiang Chen, LuLu Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Opportunely screening for diabetes is crucial to reduce its related morbidity, mortality, and socioeconomic burden. Machine learning (ML) has excellent capability to maximize predictive accuracy. We aim to develop ML-augmented models for diabetes screening in community and primary care settings. METHODS: 8425 participants were involved from a population-based study in Hubei, China since 2011. The dataset was split into a development set and a testing set. Seven different ML algorithms were compared to generate predictive models. Non-laboratory features were employed in the ML model for community settings, and laboratory test features were further introduced in the ML+lab models for primary care. The area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (auPR), and the average detection costs per participant of these models were compared with their counterparts based on the New China Diabetes Risk Score (NCDRS) currently recommended for diabetes screening. RESULTS: The AUC and auPR of the ML model were 0·697and 0·303 in the testing set, seemingly outperforming those of NCDRS by 10·99% and 64·67%, respectively. The average detection cost of the ML model was 12·81% lower than that of NCDRS with the same sensitivity (0·72). Moreover, the average detection cost of the ML+FPG model is the lowest among the ML+lab models and less than that of the ML model and NCDRS+FPG model. CONCLUSION: The ML model and the ML+FPG model achieved higher predictive accuracy and lower detection costs than their counterpart based on NCDRS. Thus, the ML-augmented algorithm is potential to be employed for diabetes screening in community and primary care settings. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9742532/ /pubmed/36518245 http://dx.doi.org/10.3389/fendo.2022.1043919 Text en Copyright © 2022 Liu, Zhang, Zhang, Chen, Zeng, Zhang, Min, Tian, Zhang, Huang, Wang, Hu and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liu, XiaoHuan
Zhang, Weiyue
Zhang, Qiao
Chen, Long
Zeng, TianShu
Zhang, JiaoYue
Min, Jie
Tian, ShengHua
Zhang, Hao
Huang, Hantao
Wang, Ping
Hu, Xiang
Chen, LuLu
Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title_full Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title_fullStr Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title_full_unstemmed Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title_short Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study
title_sort development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: a population-based study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742532/
https://www.ncbi.nlm.nih.gov/pubmed/36518245
http://dx.doi.org/10.3389/fendo.2022.1043919
work_keys_str_mv AT liuxiaohuan developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT zhangweiyue developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT zhangqiao developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT chenlong developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT zengtianshu developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT zhangjiaoyue developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT minjie developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT tianshenghua developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT zhanghao developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT huanghantao developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT wangping developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT huxiang developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy
AT chenlulu developmentandvalidationofamachinelearningaugmentedalgorithmfordiabetesscreeningincommunityandprimarycaresettingsapopulationbasedstudy